Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesRelative effectiveness of osteoporosis drugs for preventing nonvertebral fracture
Annals of Internal Medicine, 05/09/08
Cadarette SM et al. - Differences in fracture risk between risedronate or raloxifene and alendronate were small. Nasal calcitonin recipients may have a higher risk for nonvertebral fractures compared with alendronate recipients.
Methods- Aim was to compare the relative effectiveness of osteoporosis treatments to reduce nonvertebral fracture risk among older adults
- 43,135 new recipients of oral bisphosphonates, nasal calcitonin, and raloxifene
- The mean age was 79 yrs, and 96% were women
- The primary outcome was nonvertebral fracture within 12 mos of treatment initiation
- Alendronate was the reference category in all analyses
- A total of 1051 nonvertebral fractures were observed within 12 mos
- No large differences in fracture risk were found between risedronate or raloxifene and alendronate
- Among those with a fracture history, raloxifene recipients experienced more nonvertebral fractures within 12 mos vs alendronate recipients
- Pts who received calcitonin experienced more nonvertebral fractures than those who received alendronate
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/07/09
Usefulness of reagent strips for checking cure in spontaneous bacterial peritonitis after short-course treatment
Alimentary Pharmacology and Therapeutics, 12/07/09
Mercaptopurine rescue after azathioprine-induced liver injury in inflammatory bowel disease
Alimentary Pharmacology and Therapeutics, 12/07/09
Sponsor
Article Search
Sponsor